BG
SLN

Bellevue Group’s Silence Therapeutics SLN Stock Holding History

Bellevue Group’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,483
Closed -$361K – 184
2022
Q2 		$361K Sell
30,483
-16,183
-35% -$192K 0.01% 150
2022
Q1 		$887K Hold
46,666
– – 0.01% 152
2021
Q4 		$1.09M Buy
+46,666
New +$1.09M 0.01% 154